- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy for Neurodegenerative Diseases
Authors
Keywords
Gene therapy, Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, viral vector, intraoperative MRI.
Journal
Neurotherapeutics
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-12-13
DOI
10.1007/s13311-018-00694-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
- (2018) Melvin M. Evers et al. MOLECULAR THERAPY
- Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease
- (2018) Michael S. Rafii et al. JAMA Neurology
- Outcomes of Interventional-MRI Versus Microelectrode Recording-Guided Subthalamic Deep Brain Stimulation
- (2018) Philip S. Lee et al. Frontiers in Neurology
- MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain
- (2017) L Samaranch et al. GENE THERAPY
- AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
- (2017) J Miniarikova et al. GENE THERAPY
- Axonal transport of AAV9 in nonhuman primate brain
- (2016) F Green et al. GENE THERAPY
- Intraoperative MRI for deep brain stimulation lead placement in Parkinson’s disease: 1 year motor and neuropsychological outcomes
- (2016) Christos Sidiropoulos et al. JOURNAL OF NEUROLOGY
- Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease
- (2016) Jill L. Ostrem et al. JOURNAL OF NEUROSURGERY
- The Biology of Huntingtin
- (2016) Frédéric Saudou et al. NEURON
- Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
- (2016) Jana Miniarikova et al. Molecular Therapy-Nucleic Acids
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain
- (2013) W San Sebastian et al. GENE THERAPY
- Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates
- (2013) Lluis Samaranch et al. HUMAN GENE THERAPY
- Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
- (2013) A. P. Kells et al. JOURNAL OF NEUROSCIENCE
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
- (2012) Richard Grondin et al. BRAIN
- Axonal transport of adeno-associated viral vectors is serotype-dependent
- (2012) E A Salegio et al. GENE THERAPY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Safety and Tolerability of Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery of AAV2-hAADC with a Novel Delivery Platform in Nonhuman Primate Striatum
- (2011) Waldy San Sebastian et al. HUMAN GENE THERAPY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
- (2011) Jodi L McBride et al. MOLECULAR THERAPY
- Deep Brain Stimulation in Area LC Controllably Triggers Auditory Phantom Percepts
- (2011) Paul S. Larson et al. NEUROSURGERY
- Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
- (2011) R. Mark Richardson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics
- (2010) Dali Yin et al. JOURNAL OF NEUROSURGERY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors
- (2010) Xiaomin Su et al. MOLECULAR THERAPY
- Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
- (2010) Piotr Hadaczek et al. MOLECULAR THERAPY
- A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease
- (2010) Shin-ichi Muramatsu et al. MOLECULAR THERAPY
- Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia
- (2010) Agnieszka Ciesielska et al. MOLECULAR THERAPY
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease
- (2010) Francisco Valles et al. NEUROSURGERY
- Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
- (2009) Louisa C. Johnston et al. HUMAN GENE THERAPY
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates
- (2009) Dali Yin et al. NEUROIMAGE
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- ANATOMIC COMPRESSION CAUSED BY HIGH-VOLUME CONVECTION-ENHANCED DELIVERY TO THE BRAIN
- (2009) Francisco Valles et al. NEUROSURGERY
- Future Applications: Gene Therapy
- (2009) R.M. Richardson et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Efficient gene therapy-based method for the delivery of therapeutics to primate cortex
- (2009) A. P. Kells et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery
- (2008) Vanja Varenika et al. JOURNAL OF NEUROSURGERY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Argonaute proteins: key players in RNA silencing
- (2007) Gyorgy Hutvagner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started